GONGWIN BIOPHARM HOLDINGS
Gongwin Biopharm Holdings, Co., Ltd. Cayman (Gongwin-KY; ticker: 6617) founded in 2014 is a Taiwan-based clinical-stage biopharmaceutical company focused on developing novel anti-cancer drugs. they adopt an innovative anti-tumor therapy called “minimally-invasive targeted tumor ablation” (MITTA) therapy for the treatment of focal malignancies. In 2017, Gongwin-KY has been granted “Biotech New Drug Company” designation by MOEA, Taiwan and became a public trading company at Taipei Emerging Stock Board.
GONGWIN BIOPHARM HOLDINGS
Industry:
Biotechnology Health Care
Founded:
2014-01-01
Address:
Taipei, T'ai-pei, Taiwan
Country:
Taiwan
Website Url:
http://www.gongwinbiopharm.com
Status:
Active
Contact:
02-2503-5282
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager Google Universal Analytics Apache
Official Site Inspections
http://www.gongwinbiopharm.com Semrush global rank: 6.05 M Semrush visits lastest month: 1.35 K
- Host name: 199.238.155.104.bc.googleusercontent.com
- IP address: 104.155.238.199
- Location: Mountain View United States
- Latitude: 37.4043
- Longitude: -122.0748
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94043
Loading ... 